Lung Cancer
A Randomized, Double-blind, Multiregional Phase 3 Study of Ivonescimab Combined with Chemotherapy Versus Pembrolizumab Combined with Chemotherapy for the First-line Treatment of Metastatic Non- small Cell Lung Cancer (HARMONi-3) (SMT112-3003)
- Details
ClinicalTrials.gov ID:
NCT05899608
Diagnosis Type:
NA
USOR Number:
- Address
,
P: